Clincosm LogoSign in Get a demo

platinum sensitive ovarian cancer

Showing 1 - 3 of 3
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platinum Sensitive Ovarian Cancer, Ovarian Cancer Trial in United States (FRa peptide plus Adjuvant (GM-CSF), Adjuvant (GM-CSF)

Terminated
Has Results
  • Platinum Sensitive Ovarian Cancer
  • Ovarian Cancer
  • FRα peptide plus Adjuvant (GM-CSF)
  • Adjuvant (GM-CSF) Alone
  • Birmingham, Alabama
  • +17 more
Nov 21, 2022

Ovarian Tumors, Platinum Sensitive Ovarian Cancer Trial in Worldwide (Active comparator: Niraparib, )

Completed
Has Results
  • Ovarian Neoplasms
  • Platinum Sensitive Ovarian Cancer
  • Active comparator: Niraparib
  • placebo
  • Phoenix, Arizona
  • +111 more
Jan 28, 2022

Recurrent Ovarian Cancer, Platinum Sensitive Ovarian Cancer Trial in Boston (Carboplatin)

Terminated
Has Results
  • Recurrent Ovarian Cancer
  • Platinum Sensitive Ovarian Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 1, 2016